beta
Trial Radar AI

Showing clinical trials matching location: China.

I can help you find clinical trials in specific locations and provide insights on health conditions and treatments.

With advanced mode, access powerful pre-screening tools, interactive data visualizations, customized email alerts for trial updates and more.

155 Results
Top 50 Showing
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Keywords
Neoadjuvant Therapy
×
 
Location
China
×
 
Study Type
observational
×
 
Study Title
Status
Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC） NCT07388771
Recruiting
Development and Prospective Validation of a Multimodal Fusion Artificial Intelligence Model for Predicting the Efficacy of Neoadjuvant Treatment of Bladder Cancer NCT06909643
Recruiting
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy NCT06889402
Not yet recruiting
Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC NCT07135856
Recruiting
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma NCT06405321
Recruiting
Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC (NeoR-World) NCT05974007
Recruiting
Neoadjuvant Radiotherapy for High-risk UTUC (LUXUS07) NCT06472752
Not yet recruiting
A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer NCT07080021
Recruiting
Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer NCT06904677
Recruiting
The Therapeutic Efficacy of 18F-FDG Combined With 18F-FAPI PET/MR in Neoadjuvant Therapy for Gastric Cancer NCT06327386
Recruiting
Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer (NeoLATC) NCT07419932
Recruiting
Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy (NeoIM-Lung) NCT06317558
Recruiting
Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma NCT07054086
Recruiting
Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer NCT07359040
Active, not recruiting
Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer NCT06868758
Active, not recruiting
Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world Study NCT06216782
Recruiting
GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer (GzmB-PET4BC) NCT06725940
Recruiting
Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer NCT06926179
Recruiting
Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal Cancer (ctDNA-MRD-RC) NCT07393048
Recruiting
Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma NCT06574698
Recruiting
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma NCT05740995
Recruiting
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy NCT06035250
Recruiting
Clinical Treatments in Specialized Diseases of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC) NCT04908696
Recruiting
Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy (nonPHER) NCT06693037
Recruiting
The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World. NCT05263570
Recruiting
68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer NCT06559371
Recruiting
Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer NCT07352280
Recruiting
The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC） NCT06828718
Active, not recruiting
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer NCT06613165
Recruiting
Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma NCT05894369
Recruiting
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma NCT06575322
Recruiting
RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer NCT06530316
Recruiting
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma NCT06576180
Recruiting
Neoadjuvant Triple Therapy for Resectable HCC (TALENP001) NCT06569498
Recruiting
a Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC Study (ANACIIRE-1) NCT06472635
Active, not recruiting
A Real-World Study of Neoadjuvant/Conversion Therapy for Colorectal Cancer With Chemotherapy And Anti-Angiogenic Targeted Agents NCT06470178
Not yet recruiting
PET/MR Evaluation of Regression Grading After Neoadjuvant Therapy for Rectal Cancer NCT06318234
Recruiting
A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer NCT06464601
Not yet recruiting
Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC (NeoTNBCX) NCT06700382
Recruiting
Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast Cancer Patients After Neoadjuvant Therapy NCT06649565
Recruiting
Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients (LRNacHER2) NCT06722599
Recruiting
IMmune Proteomics to Predict NeoAdjuvant Chemotherapy and ImmunoTherapy Response in Gastric Cancer (IMPACT-GC) NCT06662110
Recruiting
Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI (DLARC) NCT05523245
Recruiting
The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer NCT06690645
Recruiting
An Exploratory Study on Microbial Biomarkers Associated With the Efficacy of Neoadjuvant Therapy NCT07263620
Recruiting
Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer (ONAC) NCT06155305
Recruiting
Tumor Regression Grade As Predictor of Adjuvant Therapy NCT06710665
Recruiting
FAP-targeted PET/NIR in Lung Malignant Tumors NCT07498933
Recruiting
Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients NCT06479460
Recruiting
Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer NCT06364371
Recruiting